BRONIPRA-ND ΕΝΕΣΙΜΟ ΓΑΛΑΚΤΩΜΑ
BRONIPRA-ND ΕΝΕΣΙΜΟ ΓΑΛΑΚΤΩΜΑ
Not authorised
- Newcastle disease virus, strain La Sota, Inactivated
- Infectious bronchitis virus, strain H52, Inactivated
Product identification
Medicine name:
BRONIPRA-ND ΕΝΕΣΙΜΟ ΓΑΛΑΚΤΩΜΑ
Active substance:
- Newcastle disease virus, strain La Sota, Inactivated
- Infectious bronchitis virus, strain H52, Inactivated
Target species:
-
Poultry
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Newcastle disease virus, strain La Sota, Inactivated1000000000.00/50% Embryo Infective Dose0.50millilitre(s)
-
Infectious bronchitis virus, strain H52, Inactivated100000000.00/50% Embryo Infective Dose0.50millilitre(s)
Pharmaceutical form:
-
Emulsion for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Poultry
-
Meat and offal0day
-
-
-
Subcutaneous use
-
Poultry
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AA10
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Greece
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratorios Hipra S.A.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 38157/94/10-03-1995/K-0098001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet